SCHEMBL5344713

SCHEMBL5344713

CCC1(CC)CC(NC(=O)C(=O)OC)CC(C)(C)N1OC(C)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.34
TSHR P16473 5/20 0.34
TACR1 P25103 1/20 0.34
TACR3 P29371 1/20 0.34
GAA P10253 2/20 0.33
KMT2A Q03164 3/20 0.33
CYP3A4 P08684 3/20 0.32
CYP2C19 P33261 3/20 0.32
EPHX1 P07099 2/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5353821 0.92 POLB (0.40) POLBHTTSMN1; SMN2TSHRTACR1
SCHEMBL5344532 0.90 POLB (0.40) POLBHTTSMN1; SMN2TSHRTACR1
SCHEMBL5347762 0.89 POLB (0.38) POLBHTTSMN1; SMN2TSHRTACR1
SCHEMBL5346731 0.89 TACR1 (0.43) POLBHTTSMN1; SMN2TSHRTACR1
SCHEMBL5347709 0.88 POLB (0.40) POLBHTTSMN1; SMN2TSHRTACR1
SCHEMBL5347316 0.88 HTT (0.43) POLBHTTTSHRTACR1TACR3
SCHEMBL5347456 0.87 POLB (0.39) POLBHTTSMN1; SMN2TSHRTACR1
SCHEMBL5341114 0.87 EZH2 (0.43) POLBHTTGAAKMT2AHPGD
SCHEMBL5343395 0.86 CYP3A4 (0.40) POLBHTTSMN1; SMN2TSHRGAA
SCHEMBL5344995 0.86 LMNA (0.44) POLBHTTTSHRGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624306-B2 Stabilizer for addition polymer CIBA SPECIALTY CHEMICALS CORPORATION 2003-09-23 US claimed
US-20030166939-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides NESVADBA PETER (CH) 2003-09-04 US claimed
US-20030065184-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. 2003-04-03 US claimed
CN-1319590-A 2,2,6,6, diethyl-dimethy-1-alkoxy-piperidine compound and 1-oxide CIBA SC HOLDING AG (CH) 2001-10-31 CN claimed
US-7160966-B2 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. (US) 2007-01-09 US disclosed
US-7160966-B2 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. (US) 2007-01-09 US disclosed
US-7160966-B2 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. (US) 2007-01-09 US disclosed
US-20050143539-A1 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides NESVADBA PETER (CH) 2005-06-30 US disclosed
US-6624306-B2 Stabilizer for addition polymer CIBA SPECIALTY CHEMICALS CORPORATION 2003-09-23 US disclosed
US-20030065184-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides CIBA SPECIALTY CHEMICALS CORP. 2003-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166939-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides ALKBH2, NFE2L2, DPYSL2 POLB 465/4885HTT 3742/4885SMN1; SMN2 1613/4885
US-20050143539-A1 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides ALKBH2, NFE2L2, DPYSL2 POLB 465/4885HTT 3742/4885SMN1; SMN2 1613/4885
US-20030065184-A1 2,2,6,6 diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides ALKBH2, NFE2L2, DPYSL2 POLB 465/4885HTT 3742/4885SMN1; SMN2 1613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.